Murdoch University Research Repository

Welcome to the Murdoch University Research Repository

The Murdoch University Research Repository is an open access digital collection of research
created by Murdoch University staff, researchers and postgraduate students.

Learn more

Mouse cornea transfected with plasmid containing interferon-b transgene is superior to other Type I interferon transgenes in antagonizing viral-medicated mortality

Carr, D.J., Cull, V. and James, C.M. (2002) Mouse cornea transfected with plasmid containing interferon-b transgene is superior to other Type I interferon transgenes in antagonizing viral-medicated mortality. In: Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO), 5 - 10 May, Fort Lauderdale, Florida, USA.

Abstract

Purpose:To compare the anti-viral efficacy of type I interferon (IFN) plasmid cassettes against ocular herpes simplex virus type 1 (HSV-1) infection.

Methods:Plasmid constructs containing type I IFN transgenes (575-626 base pairs) including (IFN-a1, -a4, -a5, -a6, -a9, or -b) were expressed under the control of a human CMV immediate-early enhancer/promotor. The plasmids (100 ug/eye) were topically applied to mouse corneas 24 h prior to infection with HSV-1 (McKrae strain, 240 pfu/eye). Mice were assessed for cumulative survival. In a separate experiment, mouse cornea was transfected with either the IFN-a6 or IFN-b transgene and assessed for STAT-1, IFN-inducible gene (OAS and PKR), and viral gene expression by Western blot analysis and real time PCR 24 h following in situ transfection or 24 h post infection.

Results:Recipients of the murine IFN-b or IFN-a1 transgene showed the greatest degree of protection against HSV-1-mediated mortality compared to recipients of other type I IFN transgenes and significantly (p<.05) above the null vector and IFN-a5 and IFN-a6 transgene-treated mice. Interestingly, the IFN-a6 transgene induced similar levels of STAT1 and IFN-inducible gene expression in the cornea as recipients of the IFN-b transgene prior to and 24 h following infection with HSV-1. However, cornea transfected with the IFN-b transgene but not the IFN-a6 showed a significant (3-10 fold) reduction in HSV-1 immediate early (ICP27) and early (TK) gene expression in the cornea 24 h post infection.

Conclusion:The IFN-b transgene topically applied to the cornea of mice 24 h prior to HSV-1 infection protect against viral-mediated mortality by antagonizing HSV-1 immediate early and early gene expression through PKR and OAS independent pathways that may or may not involve STAT-1 expression.

Item Type: Conference Item
Murdoch Affiliation: School of Veterinary and Biomedical Sciences
URI: http://researchrepository.murdoch.edu.au/id/eprint/24544
Item Control Page Item Control Page